Eiger BioPharmaceuticals Announces Appointment of Commercial Operations Industry Veteran Eldon Mayer to its Board of Directors

PALO ALTO, Calif., Jan. 8, 2018 -- (Healthcare Sales & Marketing Network) -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of therapies for rare diseases, announced today the appointment of Eldon Mayer to ... Biopharmaceuticals, Personnel Eiger BioPharmaceuticals
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news